Turkish Version of Telephone Based ABILOCO-Stroke
Sponsor
Pamukkale University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05582330
Collaborator
(none)
130
5.9
Study Details
Study Description
Brief Summary
The aims of this study were to perform cultural adaptation of the telephone based ABILOCO-stroke instrument and provide information regarding the factor structure, reliability and validity of the instrument in Turkish speaking patients with stroke.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
130 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Turkish Cultural Adaptation, Validation and Reliability Study of Telephone Based ABILOCO-Stroke
Anticipated Study Start Date
:
Nov 1, 2022
Anticipated Primary Completion Date
:
Apr 1, 2023
Anticipated Study Completion Date
:
May 1, 2023
Outcome Measures
Primary Outcome Measures
- Telephone Based ABILOCO-Stroke [10 minutes]
ABILOCO is a measure of locomotion ability for adults with stroke survivors.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
hemiparetic individuals who were ≥ 18 years of age
-
were at least 4 weeks after the onset of the stroke
-
able to walk with or without assistive devices.
Exclusion Criteria:
-
cognitive impairments
-
aphasia
-
any other non-stroke-related conditions.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Pamukkale University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ayşe Ünal,
Assos. Prof.,
Pamukkale University
ClinicalTrials.gov Identifier:
NCT05582330
Other Study ID Numbers:
- 13.10.2022/abiloco
First Posted:
Oct 17, 2022
Last Update Posted:
Oct 17, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: